Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study.

Mathurin FumeryStéphane NanceyJérôme FilippiRomain AltweggXavier HébuterneGilles BoshettiMathilde BarraudJonathan MeynierStéphane Paul Xavier Roblin

Published in: Alimentary pharmacology & therapeutics (2023)

In this prospective multicentric study, half of patients recaptured response following golimumab intensification in UC. Therapeutic drug monitoring did not predict response after optimisation of golimumab.

Keyphrases

ulcerative colitis
end stage renal disease
ankylosing spondylitis
ejection fraction
randomized controlled trial
newly diagnosed
chronic kidney disease
systematic review
peritoneal dialysis
systemic lupus erythematosus